Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01112514
Other study ID # 09-398
Secondary ID
Status Completed
Phase N/A
First received April 27, 2010
Last updated January 8, 2014
Start date February 2010
Est. completion date April 2013

Study information

Verified date January 2014
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Standard white light endoscopy involves the passage of a thin, flexible camera into the colon from the anus. Although standard white light endoscopy can detect most polyps and precancerous areas in the gastrointestinal tract and colon, many studies have shown that even the most experienced doctors, under optimal conditions, can miss up to 15-25% of precancerous areas. Thus, there remains a clear need to develop new methods of improving standard white light endoscopy. We are investigating whether indocyanine green (ICG) can serve to highlight areas which are precancerous when the colon is visualized with a special cameral which shines fluorescent light. Information from other studies suggests that this ICG agent may help to visualize blood vessels flowing to precancerous areas in the colon. We are looking at the ability of ICG, in combination with an endoscope which shines fluorescent light, to visualize precancerous areas in the colon.


Description:

- Participants will be scheduled for their regular lower endoscopy. On the day of the procedure, participants will come to the endoscopy unit at Massachusetts General Hospital. After arriving, participants will receive an intravenous line and meet with the research doctor to go over the procedure. The participant will then be transferred to the endoscopy procedure room and be administered sedatives until they are comfortable to proceed with the procedure.

- The research doctor will pass the flexible study sigmoidoscope into the lower part of the rectum. At this time, a dose of the ICG contrast agent will be administered through the intravenous line. Any areas that are suspicious will be photographed using the camera in the scope. We will also biopsy/remove any suspicious areas and send it to the pathologist as we normally do during endoscopy.

- Over the course of the study procedure, small doses of ICG will be administered to help find any precancerous areas. Altogether, the study exam should not take more than 10 to 15 minutes.


Recruitment information / eligibility

Status Completed
Enrollment 4
Est. completion date April 2013
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Participants will include patients with high risk polyposis syndromes with planned routine endoscopic surveillance for neoplasia or patients with planned endoscopic evaluation of distal colonic lesions suspicious for colorectal polyps or cancer detected on abdominal imaging

- Fit for conscious sedation or monitored anesthesia care for colonoscopy-American Society of Anesthesiologists (ASA) Class I or II

- 18 years of age or older

- Eastern Cooperative Oncology Group (ECOG) Performance status 0-2

- Negative human chorionic gonadotropin (HCG) test for women of child-bearing age. Women of child-bearing potential and men must agree to use adequate contraception prior to study entry and for the duration of study participation

Exclusion Criteria:

- Participants with AsA class III, IV, V

- Documented allergy to iodine, iodine-containing compounds of ICG

- Documented allergy to sulfur containing compounds

- History of allergic reactions attributed to compounds of similar chemical or biologic composition to ICG

- History of adverse reactions to endoscopy or sedatives for endoscopy

- Pregnant or breast-feeding women

- Participants who are unable to discontinue warfarin anticoagulation 5 days before the procedure

- Participants taking phenobarbital, phenylbutazone, primidone, phenytoin, haloperidol, nitrofurantoin, probenecid

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Drug:
indocyanine green
Administered intravenously during endoscopic near-infrared (NIR) imaging

Locations

Country Name City State
United States Dana-Farber Cancer Institute Boston Massachusetts
United States Massachusetts General Hospital Boston Massachusetts

Sponsors (4)

Lead Sponsor Collaborator
Massachusetts General Hospital Damon Runyon Cancer Research Foundation, Dana-Farber Cancer Institute, National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Neoplastic Lesions Detected upto 15 mins No
See also
  Status Clinical Trial Phase
Completed NCT02595775 - A Trial of an Audit and Feedback Report to Improve Colonoscopy Performance N/A
Completed NCT01950117 - Complete Removal of Neoplastic Large Colorectal Polyps: a Prospective Randomized Comparison of Endoscopic Mucosal Resection or Conventional Polypectomy N/A
Completed NCT01486745 - Urine Metabolomics and Colorectal Cancer Screening
Completed NCT02284802 - Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy N/A
Completed NCT04727918 - Comparison of Cold Biopsy Forceps vs Cold Snare for Diminutive Colorectal Polyp Removal N/A
Completed NCT00298545 - Effect of Vitamin D and Calcium on Genes in the Colon Phase 1
Completed NCT01262248 - Computer-based Classification of Colorectal Polyps Using Narrow-band Imaging N/A
Completed NCT00988676 - The Effect of Bowel Preparation Status on the Polyp Missing Rate N/A
Recruiting NCT03787784 - Automatic Classification of Colorectal Polyps Using Probe-based Endomicroscopy With Artificial Intelligence N/A
Completed NCT00622557 - General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)
Completed NCT01553565 - Prospective Comparison of Cold Polypectomy and Conventional Polypectomy for Small Colorectal Polyps in Patients Taking Antithrombotic Agents N/A
Active, not recruiting NCT03699163 - The Colorectal Breath Analysis (COBRA) Study
Completed NCT01633333 - Water Exchange Versus Carbon Dioxide for Colonoscopy N/A
Recruiting NCT03620695 - Confocal Laser Endomicroscopy With Topical Cresyl Violet for Colorectal Polyps
Completed NCT00204867 - Virtual Colonoscopy (VC) for Primary Colorectal Screening N/A
Active, not recruiting NCT02887573 - Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy Phase 4
Not yet recruiting NCT02033980 - Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions N/A
Completed NCT02217449 - Virtual Chromoendoscopy for Distal Polyps
Completed NCT00725465 - Prospective Evaluation of Combined Laparoscopy With CO2 Intraoperative Colonoscopy Treatment for Colorectal Lesions
Completed NCT02354287 - Effectiveness of Cold Biopsy Forceps With Pre-lift for Complete Resection of Colonic Polyps ≤7mm in Size N/A